Clinical outcomes of non–small cell lung cancer patients with leptomeningeal metastases after immune checkpoint inhibitor treatments.
Saved in:
| Title: | Clinical outcomes of non–small cell lung cancer patients with leptomeningeal metastases after immune checkpoint inhibitor treatments. |
|---|---|
| Authors: | Zheng, Mei-Mei1 (AUTHOR), Tu, Hai-Yan1 (AUTHOR), Yang, Jin-Ji1 (AUTHOR), Zhang, Xu-Chao1 (AUTHOR), Zhou, Qing1 (AUTHOR), Xu, Chong-Rui1 (AUTHOR), Jiang, Ben-Yuan1 (AUTHOR), Yang, Xue-Ning1 (AUTHOR), Yang, Xiao-Rong1 (AUTHOR), Deng, Jia-Yi1 (AUTHOR), Yang, Ming-Yi1 (AUTHOR), Xu, Bing-Fei1 (AUTHOR), Chen, Xiu-Mei1 (AUTHOR), Li, Yang-Si1 (AUTHOR) liyangsi69@126.com, Wu, Yi-Long1 (AUTHOR) syylwu@live.cn |
| Source: | European Journal of Cancer. Jun2021, Vol. 150, p23-30. 8p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09598049 |
|---|---|
| DOI: | 10.1016/j.ejca.2021.03.037 |
